Abstract
Summary:
- Serum eosinophil-derived neurotoxin levels correlate with eosinophil activation and disease activity in atopic dermatitis.
- Reduced serum eosinophil-derived neurotoxin levels after cyclosporine therapy indicate treatment response and efficacy monitoring potential.
To the Editor,
Eosinophils play a key role in atopic diseases and blood eosinophil counts are being used as a predictive biomarker for asthma subtype and treatment response. However, [...]
- Serum eosinophil-derived neurotoxin levels correlate with eosinophil activation and disease activity in atopic dermatitis.
- Reduced serum eosinophil-derived neurotoxin levels after cyclosporine therapy indicate treatment response and efficacy monitoring potential.
To the Editor,
Eosinophils play a key role in atopic diseases and blood eosinophil counts are being used as a predictive biomarker for asthma subtype and treatment response. However, [...]
| Original language | English |
|---|---|
| Pages (from-to) | 1084-1086 |
| Number of pages | 3 |
| Journal | Clinical and Experimental Allergy |
| Volume | 56 |
| Issue number | 9 |
| Early online date | 12 May 2026 |
| DOIs |
|
| Publication status | Published - Sept 2026 |
Bibliographical note
© 2026 The Author(s). Clinical & Experimental Allergy published by John Wiley & Sons Ltd.Fingerprint
Dive into the research topics of 'Serum Eosinophil-Derived Neurotoxin (EDN) as a Biomarker for Treatment Response in Atopic Dermatitis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver